$HDII HDII post triangle thrust and 0.618 extension of Y to complete Z at $0.22 (confluence) primary target
watching the low at $0.0865.. long yesterday from $0.1065
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
91.74 M
About Hypertension Diagnostics, Inc.
Sector
Industry
CEO
Liangjian Peng
Headquarters
Richmond Hill
Founded
1988
FIGI
BBG000C4T988
Hypertension Diagnostics, Inc. engages in the business of plastic reprocessing. It provides pelletized resin and clean shredded and ground plastics material through its subsidiary. The company was founded by Jay N. Cohn and Stanley M. Finkelstein on July 19, 1988 and is headquartered in Richmond Hill, Canada.
HDIIpartnered with major china firm telecom and in cahouts with 4 other major china telecoms looking for a way into usa via hdii. Could be a something and maybe not, worth some homework perhaps....
HDII upcoming mergerlocked & loaded. Rumor has it that the attorney got the papers to remove control dispute -> .2+ real quick when merger news comes through. Xu will get it done.
HDIIHuge momentum building up on the merger news.
Rumor has it that 150 million+ annual rev Chinese company buying up (taking over) a ~~4million market cap company to get market exposure in the US
HDII filed all there SEC documents last week (7filings)
Huge breakout into 0.1 - 0.5 soon!
$HDii On Major Breakout Following The Release of ALL Filings R/M$HDII Today dropped all required filings for the past 3 Years. The following iHub Posts has more DD on this amazing R/M that could end up being as big as $DCGD
investorshub.advfn.com
investorshub.advfn.com
investorshub.advfn.com
investorshub.advfn.com
investorshub.advfn.com
investorshub.advfn.com
HDIISources say this is a 50x - 100x bagger.
8k showed that this is another reverse merger play like CLSI and DCGD.
The buyer is some Chinese company - link: twitter.com
150million+ company buying a 2.2million market cap shell. Current valuation will explode:)
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HDII is 0.000001 USD — it hasn't changed in the past 24 hours. Watch Hypertension Diagnostics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hypertension Diagnostics, Inc. stocks are traded under the ticker HDII.
HDII reached its all-time high on Aug 17, 2000 with the price of 8.437500 USD, and its all-time low was 0.000001 USD and was reached on Feb 26, 2024. View more price dynamics on HDII chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HDII stock is 0.00% volatile and has beta coefficient of −162.50. Track Hypertension Diagnostics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hypertension Diagnostics, Inc. there?
Yes, you can track Hypertension Diagnostics, Inc. financials in yearly and quarterly reports right on TradingView.
Hypertension Diagnostics, Inc. is going to release the next earnings report on Feb 21, 2025. Keep track of upcoming events with our Earnings Calendar.
No, HDII doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HDII shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hypertension Diagnostics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hypertension Diagnostics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hypertension Diagnostics, Inc. stock shows the sell signal. See more of Hypertension Diagnostics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.